Severity of metabolic syndrome unfavorably influences oxidative stress and fatty acid metabolism in men

Tohoku Journal of Experimental Medicine

Volumn 212, Issue 4, 2007, Pages 359-371

  Žák, Aleš ^a   Tvrzická, Eva ^a   Vecka, Marek ^a   Jáchymová, Marie ^a   Duffková, Ladislava ^a   Stanková, Barbora ^a   Vávrová, Lucie ^a   Kodydková, Jana ^a   Zeman, Miroslav ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Fatty acid composition; Metabolic syndrome components; Oxidative stress

Indexed keywords

ACYL COENZYME A DESATURASE; APOLIPOPROTEIN E; DELTA5 DESATURASE; FATTY ACID BINDING PROTEIN; GLUCOSE; INSULIN; ISOPROTEIN; LINOLEOYL COENZYME A DESATURASE; LOW DENSITY LIPOPROTEIN; OXYGENASE; SATURATED FATTY ACID; THREONINE; UNCLASSIFIED DRUG; FATTY ACID;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FATTY ACID METABOLISM; GENE FREQUENCY; GENETIC POLYMORPHISM; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; INSULIN BLOOD LEVEL; LIPID COMPOSITION; LIPID METABOLISM; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; MEN'S HEALTH; METABOLIC SYNDROME X; OXIDATIVE STRESS; PATHOPHYSIOLOGY; TREND STUDY; DIET; METABOLISM; MIDDLE AGED;

ADULT; DIET; FATTY ACIDS; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OXIDATIVE STRESS;

EID: 38449103799     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.212.359     Document Type: Article

References (62)

1. Aarsland, A., Chirkes, D. & Wolfe, D.R. (1907) Hepatic and whole-body fat synthesis in humans during carbohydrate overfeeding. Am. J. Clin. Nutr., 65, 1774-782.
2. Ahotupa, M., Ruutu, M. & Mantyla, E. (1996) Simple methods of quantifying oxidation products and antioxidant potential of low density lipoproteins. Clin. Biochem., 29, 139-144.
3. Alberti, K.G., Zimmet, P. & Shaw, J. (2006) Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet, Med., 23, 469-480.
4. Austin, M.A. & Selby, K.V. (1995) LDL subclass phenotypes and the risk factors of the insulin resistance syndrome. Int. J. Obes. ReLat. Metab. Pisord., 19, Suppl. 1, S22-S26.
5. Avramoglu, R.K., Basciano, H. & Adeli, K. (2006). Lipid and lipoprotein dysregulation in insulin resistant states. Clin. Chim. Acta, 368, 1-19.
6. Bergeron, N. & Havel, R.J. (1996) Prolonged postprandial responses of lipids and apolipoproteins in triglyceride-rich lipoproteins of individuais expressing an apolipoprotein E epsilon 4 allele. J. Clin. Invest., 97, 65-70.
7. Campos, H., D'Agostino, M. & Ordovas, M. (2001) Gene-diet interactions and plasma lipoproteins: role of apolipoprotein E and habitual saturated fat intake. Genet. Epidemiol., 20, 117-128.
8. Carpentier, Y.A., Portois, L. & Malaisse, W.J. (2006) n-3 fatty acids and the metabolic syndrome. Am. J. Clin. Nutr., 83, Suppl., 1499S-1504S.
9. Ceriello, A. & Motz, E. (2004) Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes and cardiovascular disease? The common soil hypothesis revisited. Arterioscler. Tromb. Vasc. Biol., 24, 816-823.
10. Chan, D.C., Barrett, P.H. & Watts, G.R (2006) Recent studies of lipoprotein kinetics in the metabolic syndrome and related disorders. Curr. Opin. Lipidol., 17, 28-26.
11. Cohn, G.S, Kittleson, M.K. & Blumenthal, R.S. (2005) Toward an Improved Diagnosis of the Metabolic Syndrome. Other Clues to the Presence of Insulin Resistance. Am. J. Hypertens., 18, 1099-1103.
12. Cushman, M., Arnold, A.M., Psaty, B.M., Manolio, T.A., Kuller, L.H., Burke, L.H., Polak, J.F. & Tracy, R.P. (2005) C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study. Circulation, 112, 25-31.
13. Damcott, C.M., Feingold, E., Barmana, M.M., Marshall, J.A., Hamman, R.F. & Ferrell, R.E. (2003). Variation in the FABP2 promotor alter transcriptional activity and is associated with body composition and plasma lipid levels. Hum. Genet., 112, 610-616.
14. Decsi, T., Csábi, G., Török, K., Erhardt, E., Hajnalka, M., Burus, I., Molnaár, S. & Molnár, D. (2006) Polyunsaturated fatty acids in plasma lipids of obese childlen with and without metabolic cardiovascular syndrome. Lipids, 35, 1179-1184.
15. Dixon, W.J. (1992) BMDP Statistical Software Manual, 1-2, University of California Press, Los Angeles, CA, USA, Berkeley.
16. Durnin, J.V.G.A. & Womersley, J. (1974) Body fat assessed from the total body density and its estimation from skinfold thickness: measurements on-481 men and women aged from 16 to 71 years. Br J. Nutr., 32, 77-97.
17. Edwards, K.L, Austin, M.A., Newman, B., Mayer, E., Krauss, R.M. & Selby, J.V. (1994) Multivariate analysis of the insulin resistance syndrome in women. Arterioscl. Thromb., 14, 1940-1945.
18. Erkkila, A.T., Sarkkinen, E.S., Lindi, V., Lehto, S., Laakso, M. & Uusitupa, M.I. (2001) APOE polymorphism and the hypertriglyceridemic effect of dietary sucrose. Am. J. Clin. Nutr., 73, 746-752.
19. Fernandez-Miranda, C., Cancelas, P., Sanz, M., Porres, A. & Gamez Gerique, J. (2001) Influence of apolipoprotein-E phenotypes on postprandial lipoprotein metabolism after three different fat loads. Nutrition, 17, 529-533.
20. Fujita, K., Nishizawa, H., Funahashi, T., Shimomura, I. & Shimabukuro, M. (2006) Systemic oxidative stress is associated with visceral fat accumulalon and the metabolic syndrome. Circ. J., 70, 1437-1442.
21. Furukawa, S., Fujita, K., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M. & Shimomura, I. (2004) Increasod oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest., 114, 1752-1761.
22. Greenberg, A.S. & McDaniel, M.L. (2002) Identifying the links between obesity, insulin, resistance and β-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes. Eur. J. Clin. Invest., 32, 24-34.
23. Grundy, S.M. (2006) Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy. Nature Review, 5, 295-304.
24. Hixson, J.E. & Vernier, D.T. (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res., 31, 545-548.
25. Holman, R.T., Adams, C.E., Nelson, R.A., Grater, S.J.E., Jaskiewicz, J.A., Johnson, S.B. & Erdman, J.W. (1995) Patients with anorexia nervosa demonstrate deficiencies of selected essential fatty acids, compensatory changes in nonessential fatty acids and decreased fluidity of plasma lipids. J. Nutr., 125, 901-907.
26. Ishii, T., Hirose, H., Kawai, T., Hayashi, K., Maruyama, H., Saito, I. & Saruta, T. (2001) Effects of intestinal fatty-acid-binding protein gene Ala64Arg polymorphism on insulin resistance and fasting plasma glucose in young to older Japanese men. Metabolism, 50, 1301-1307.
27. Jáchymová, M., Horký, K., Bultas, J., Kožich, V., Jindra, A., Peleška, J. & Martásek, P. (2001) Association of the Glu298Asp polymorphism in the endothelial nitric oxide synthase gene with essential hypertension resistant to conventional therapy. Biochem. Biophys. Res. Commun., 284, 426-430.
28. Klein-Platat, C., Drai, J., Oujaa, M., Schlienger, J.-L. & Simon, C. (2005) Plasma fatty acid composition is associated with the metabolic syndrome and low grade inflammation in overweight adolescents. Am. J. Clin. Nutr., 82, 1178-1184.
29. Laakso, M. (2004) Gene variants, insulin resistance, and dyslipidaemia. Curr. Opin. Lipidol., 15, 115-120.
30. Laaksonen, D.E., Lakka, T.A., Lakka, H.-M., Nyyssönen, K., Rissanen, T. & Niskanen, L.K. (2002) Serum fatty acid composition predicts development of impaired fasting glycaemia and diabetes in middle-aged men. Diabet. Med., 19, 456-464.
31. Lahoz, C., Schaefer, E.J., Cupples, L.A., Wilson, P.W., Levy, D., Osgood, D., Parpos, S., Pedro-Botet, J., Daly, J.A. & Ordovas, J.M. (2001) Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. Atherosclerosis, 154, 529-537.
32. Leskinen, M.H.,.Solakivi, T., Kunnas, T., Alho, H. & Nikkari, S.T. (2005) Serum fatty acids in postinfarction middle-aged men. Scand. J. Clin. Lab. Med., 65, 485-490.
33. Levy, E., Menard, D., Delvin, E., Stan, S., Mitchell, G., Lambert, M., Ziv, E., Feoli-Fonseca, J.C. & Seidman, E. (2001) The polymorphism at codon 54 of the FABP2 gene increases fat absorption in human intestinal explants. J. Biol. Chem., 276, 39679-39684.
34. Lindgärde, F., Vessby, B. & Ahrén, B. (2006) Serum cholesteryl fatty acid composition and plasma glucose concentrations in American women. Am. J. Clin. Nutr., 84, 1009-1013.
35. Lochman, T., Roche, A. & Martorel, R. (1989) Standardization of anthropometric measurements. Human Kinetics Publishers, Champaign, IL, pp. 39-80.
36. Loevinger, B., Muller, D., Alonso, C. & Coe, C.L. (2007) Metabolic syndrome in women with chronic pain. Metabolism Clin. Exp., 56, 87-93.
37. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F. & Turner, R.C. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419.
38. Miller, S.A., Dykes, D.D. & Polesky, H.F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res., 16, 1215.
39. Miranda, P.J., DeFronzo, R.A. & Califf, R.M. (2005) Metabolic syndrome: definition, pathophysiology, and mechanisms. Am. Heart J., 149, 33-45.
40. Nesto, R.W. (2003) The relation of insulin resistance syndromes to risk of cardiovascular disease. Rev. Cardiovasc. Med., 4, S11-S18.
41. Ohara, Y., Peterson, T.E. & Harrison, D.G. (1993) Hypercholesterolemia increases endothelial superoxide anion production. J. Clin. Invest., 91, 1163-1186.
42. Okada, T., Furuhashi-Sato, N., Kuromori, Y., Miyashita, M., Iwata, F., Hara, M., Harada, K. & Hattori, H. (2006) Thr-encoding allele homozygosity at codon 54 of FABP 2 gene may be associated with impaired delta 6 desaturase activity and reduced plasma arachidonic acid in obese children. J. Atheroscl. Thromb., 13, 192-196.
43. Park, Y.-W., Shankuan, Z., Palaniappan, L., Heshka, S., Carnethon, M.R. & Heymsfield, S.B. (2003) The metabolic syndrome. Prevalence and associated risk factor findings in the US population form the 3rd National Health and Nutritional Examination Survey, 1998-1994. Arch. Int. Med., 163, 427-436.
44. Park, S.H., Lee, W.Y., Rhee, E.J., Jeon, W.K., Kim, B.I., Ryu, S.H. & Kim, S.W. (2005) Relative risk of the metabolic syndrome according to the degree of insulin resistance in apparently healthy Korean adults. Clin. Sci., 108, 553-559.
45. Reiber, I., Mezo, I., Kalina, A., Palos, G., Romics, L. & Csaszar, A. (2003) Postprandial triglyceride levels in familial combined hyperlipidemia. The role of apolipoprotein E and lipoprotein lipase polymorphisms. J. Nutr. Biochem., 14, 394-400.
46. Renner, W., Pressl, H., Wascher, T.C., Paulweber, B., Malaimare, L. & Iglseder, B. (2004) The role of the A54T polymorphism of the intestinal fatty acid binding protein for lipid levels, insulin sensitivity and carotid atherosclerosis. Atherosclerosis, 173, 137-139.
47. Retnakaran, R., Zinman, B., Connelly, P.W., Harris, S.B. & Hanley, A.J. (2006) Nontradional cardiovascular risk factors in pediatric metabolic syndrome. J. Pediatr., 148, 149-151.
48. Riccardi, G., Giacco, R. & Rivellese, A. (20047 Dietary fat, insulin sensitivity and metabolic syndrome. Clin. Nutr., 23, 447-456.
49. Sattar, N., Williams, K., Sniderman, A.D., D'Agostino, R., Jr. & Haffner, S.M. (2004) Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis Study. Circulation, 110, 2687-2693.
50. Schumaker, V.N. & Puppione, D.I. (1986) Sequential flotation ultracentrifugation. Methods Enzymol., 128, 155-170.
51. Simopoulos, A.P. (2003) Importance of the ratio of omega-6/omega-3 essential fatty acids: evolutionary aspects. In: Omega-6/Omega-3 Essential Fatty Acid Ratio: the Scientific Evidence, edited by A.P. Simopoulos & L.G. Cleland, Karger, Basel, pp. 1-22.
52. Sjogren, P., Basu, S., Rosell, M., Silveira, A., de Faire, U., Vessby, B., Hamsten, A., Hellenius, M.-L. & Fisher, R.M. (2005) Measures of oxidized low-donsity lipoprotein and oxidative stress are not related and oot elevated in otherwise healthy men with the metabolic syndrome. Arterioscl. Thromb. Vasc. Biol., 25, 2580-2589.
53. Tammi, A., Rönnemaa, T., Rask-Nissilä, L., Miettinen, T.A., Gylling, H., Valsta, L., Viikari, J., Välimäki, I. & Simell, O. (2001) Apolipoprotein E phenotype regulates cholesterol absorption in healthy 13-month-old children. The STRIP Study. Pediatr. Res., 50, 688-691.
54. Tvrzická, E., Vecka, M., Staňková, B. & Žák, A. (2002) Analysis of fatty acids in plasma lipoproteins by gas chromatography-flame ionisation detection. Quantitative aspects. Anal. Chim. Acta, 465, 337-350.
55. Van Guilder, G.P., Hoetzer, G.L., Greiner, J.J., Stauffer, B.L. & DeSouza, C.A. (2006) Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults. Obesity, 14, 2127-2131.
56. Vessby, B. (2003) Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Curr. Opin. Lipidol., 14, 15-19.
57. Vidgren, H.M., Sipiläinen, R.H., Heikkinen, S., Laakso, M. & Uusitupa, M.I.J. (1997) Threonine allele in codon 54 of the fatty acid binding protein 2 gene does not modify the fatty acid ccmposition of serum lipids in obese subjects. Eur. J. Clin. Invest., 27, 405-408.
58. Warensjö, E., Riserus, U. & Vessby, B. (2005) Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men. Diabetologia, 48, 1999-2005.
59. Warensjö, E;, Sundström, J., Lind, L. & Vessby, B. (2006) Factor analysis of fatty acids in serum lipids as a measure of dietary fat quality in relation to the metabolic syndrome in men. Am. J. Clin. Nutr., 84, 442-448.
60. Yamada, K., Yuan, X., Ischiyama, S., Koyama, K., Ichikawa, F., Koyanagi, A., Koyama, W. & Nonaka, K. (1997) Association between Ala54Thr substitution of the fatty acid-binding protein 2 gene with insulin resistance and intra-abdominal fat thickness in Japanese men. Diabetologia, 40, 706-710.
61. Yazu, K., Yamomoto, Y., Ukegawa, K. & Niki, E. (1996) Mechanism of lower oxidability of eicosapentaenoate than linoleate in aqueous micelles. Lipids, 31, 337-340.
62. Zanolin, E.M., Tosi, F., Castello, R., Spiazza, G., Dorizzi, R., Muggeo, M. & Moghetti, P. (2006) Clustering of cardiovascular risk factors associated with the insulin resistance syndrome. Diabetes Care, 29, 372-378.